CN Patent

CN104324015B — 药物组合物

Assigned to Sankyo Co Ltd · Expires 2018-08-28 · 8y expired

What this patent protects

本发明提供在宽的pH范围内显示良好的溶出性的制剂。所述药物组合物含有：(A)下述式(1)表示的N 1 ‑(5‑氯吡啶‑2‑基)‑N 2 ‑((1S，2R，4S)‑4‑[(二甲基氨基)羰基]‑2‑{[(5‑甲基‑4，5，6，7‑四氢噻唑并[5，4‑c]吡啶‑2‑基)羰基]氨基}环己基)乙二酰胺、其药理上可接受的盐、或它们的水合物；和(B)选自糖醇类和水溶胀性添加剂中的1种或2种以上。

USPTO Abstract

本发明提供在宽的pH范围内显示良好的溶出性的制剂。所述药物组合物含有：(A)下述式(1)表示的N 1 ‑(5‑氯吡啶‑2‑基)‑N 2 ‑((1S，2R，4S)‑4‑[(二甲基氨基)羰基]‑2‑{[(5‑甲基‑4，5，6，7‑四氢噻唑并[5，4‑c]吡啶‑2‑基)羰基]氨基}环己基)乙二酰胺、其药理上可接受的盐、或它们的水合物；和(B)选自糖醇类和水溶胀性添加剂中的1种或2种以上。

Drugs covered by this patent

Patent Metadata

Patent number
CN104324015B
Jurisdiction
CN
Classification
—
Expires
2018-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Sankyo Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.